The University of Chicago Header Logo

Connection

Daniel Appelbaum to Neuroendocrine Tumors

Back to Details
This is a "connection" page, showing publications Daniel Appelbaum has written about Neuroendocrine Tumors.
Daniel Appelbaum
Connection Strength
0.208
Neuroendocrine Tumors
  1. MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
    View in: PubMed
    Score: 0.208
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.